224 filings
15-12G
PLXPQ
PLx Pharma Winddown Corp.
18 Oct 23
Securities registration termination
4:01pm
8-K
PLXPQ
PLx Pharma Winddown Corp.
20 Sep 23
Bankruptcy or Receivership
4:39pm
8-K
PLXPQ
PLx Pharma Winddown Corp.
22 Aug 23
Other Events
5:24pm
8-K
PLXPQ
PLx Pharma Winddown Corp.
21 Jul 23
Other Events
5:29pm
8-K
PLXPQ
PLx Pharma Winddown Corp.
12 Jul 23
Other Events
12:00am
8-K
bs2 iodvj2e8d4
7 Jul 23
Departure of Directors or Certain Officers
4:16pm
8-K
7hmy6 716oy
27 Jun 23
Other Events
4:47pm
8-K
n1wkbmgpx9n5yf6v7
26 May 23
Entry into a Material Definitive Agreement
4:19pm
25-NSE
4us6pz etpaacy2xxzf
2 May 23
Exchange delisting
1:35pm
8-K
l75i3j1ylgg9hk
13 Apr 23
Bankruptcy or Receivership
4:38pm
8-K
ij9 ipcgbhm3vbtt4
12 Apr 23
PLx Pharma Inc. Enters into a Stalking Horse Asset Purchase Agreement to Sell VAZALORE® and Substantially All of its Assets
5:29pm
8-K
awj3qni r6
10 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
cm3opqe5vum8bupfm
8 Mar 23
Departure of Directors or Certain Officers
4:42pm
8-K
67otfhq23no0inkq
13 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm
8-K
mbh cv3g23
20 Jan 23
Departure of Directors or Certain Officers
5:00pm
8-K
t31t hf4drzsu384nm
10 Nov 22
PLx Pharma Inc. Reports Third Quarter 2022 Results and Provides Business Update
5:12pm
8-K
mmrggs
7 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
DEFA14A
x2ebb7p8m4n7 z8s2tb
29 Sep 22
Additional proxy soliciting materials
4:45pm